0105

Autoimmune

Synexa specialises in biomarker and bioanalytical services which can be specifically tailored to suit both the modality of the therapeutic and the disease area of focus. Autoimmune conditions are highly heterogenous, affecting numerous cell types, molecular pathways and tissues, necessitating multi-pronged approaches integrating technology platforms including targeted genetic analysis, soluble biomarkers and flow cytometry.

Autoimmune

01

0205

Oncology

Synexa’s expertise in the field of immunology and immune-based analytical technologies makes us the perfect partner in advancing oncology therapeutic pipelines. We use innovative approaches and validated platforms to answer client-specific questions for quality, clinically-relevant data.

Oncology

02

0305

Vaccines

Accelerate vaccine development and evaluation with our comprehensive suite of bioanalytical services, supporting safety, immunogenicity, and efficacy assessments for a wide range of vaccine candidates.

Vaccines

03

0405

Cell & Gene Therapy

Advanced bioanalytical solutions for cell and gene therapies, providing comprehensive characterization, quantification, and safety assessment to support the development of innovative treatment approaches.

Cell & Gene Therapy

04

0505

Biosimilars

Robust analytical solutions for biosimilar development, offering comparative bioanalysis, potency assays, and structural characterization to ensure similarity to reference biologics and meet regulatory requirements.

Biosimilars

05